Atul spurts on receiving USFDA approval for Dapsone manufacture facility

15 Jan 2015 Evaluate

Atul is currently trading at Rs. 1453.85, up by 93.60 points or 6.88 % from its previous closing of Rs. 1360.25 on the BSE.

The scrip opened at Rs. 1365.80 and has touched a high and low of Rs. 1514.00 and Rs. 1360.95 respectively. So far 29423 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1495.00 on 22-Sep-2014 and a 52 week low of Rs. 395.10 on 04-Feb-2014.

Last one week high and low of the scrip stood at Rs. 1398.00 and Rs. 1280.10 respectively. The current market cap of the company is Rs. 4324.68 crore.

The promoters holding in the company stood at 50.68 % while Institutions and Non-Institutions held 17.88 % and 31.45 % respectively.

Atul’s Dapsone manufacture facility located at Valsad in state of Gujarat has been approved by the US Food and Drug Administration (USFDA).

The company has two business segments, namely, ‘Life Science Chemicals’ and ‘Performance and Other Chemicals’. The Life Science Chemical segment comprises several manufacturing facilities which also include Dapsone manufacture facility.

Atul is a member of Lalbhai Group, one of the oldest business houses of India, with interests mainly in textiles and chemicals. The Group is strongly committed to serve the society in the fields of education, health as well as culture

Atul Share Price

5862.10 110.00 (1.91%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×